Multiple studies show the combination potential of vedotin antibody-drug conjugates (ADCs) with pembrolizumab, including the first Phase 1 data in thoracic cancers for two first-in-class ADCs
Jadhav has completed his B.Pharmacy and is having 30+ years of rich experience in operation management in pharmaceutical Industry
He is an experienced professional in the pharmaceutical industry with about 30 years of progressive experience
Efficacy and safety from this phase IV study were consistent with data from the Vabysmo phase III DME studies
These gummies are specially formulated for both kids and adults to nourish the eyes and promote optimal vision development
Vabysmo PFS is the first and only syringe prefilled with an FDA-approved bispecific antibody to treat retinal conditions that can cause blindness
Dr Madhu will oversee Apollo's hospital business and will focus on continuing to deliver the world's best clinical outcomes
The company is confident of addressing all the observations within the stipulated time
The company achieved 100% capacity utilisation in the division. These accomplishments stand as a testament to the company's dedication and vision
As Caeregen’s CDMO partner for CTR-107, Wacker Biotech will produce drug substance at its site in Halle, Germany, and complete clinical trial drug product production at its site in Amsterdam, the Netherlands
Subscribe To Our Newsletter & Stay Updated
